ArticleJournal of cardiovascular electrophysiology2026
The Resynchronization Effect in Left Bundle Branch Pacing Can be Evaluated Non-Invasively With the Implementation of Lead V8.
Article in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Non-invasive assessment of left atrial activation using lead V8 during Bachmann bundle pacing.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026Article
- The Resynchronization Effect in Left Bundle Branch Pacing Can be Evaluated Non-Invasively With the Implementation of Lead V8.Journal of cardiovascular electrophysiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundLeft bundle branch area pacing (LBBAP) is increasingly being used for cardiac resynchronization therapy (CRT); however an additional left ventricular (LV) lead is required when resynchronization remains incomplete. This study evaluates whether lead V8 can provide a simple, non-invasive marker of persistent posterolateral LV delay during LBBAP.
methodsConsecutive patients undergoing LOT-CRT implantation were included. Standard 12-lead ECGs were obtained with the V5 electrode repositioned to the V8 location. Local activation time was measured as the steepest negative downslope of the QRS (negative derivative activation time, NDAT) and compared with the LV electrical delay (LVED) determined from the LV lead during LBBAP.
resultsThirty consecutive patients undergoing LOT-CRT implantation were included with a total of 106 ECG recordings with corresponding LVED measurements. The NDAT-V8 demonstrated a strong correlation with the LVED during intrinsic conduction (r = 0.95) and during all LBB pacing subtypes: combined r = 0.922; mean difference 2.5 ± 8 ms; RV septal pacing, r = 0.89; LV septal pacing, r = 0.92; non-selective LBBP, r = 0.91; and selective LBBP, r = 0.81. The correlation of LVED during intrinsic conduction and all LBBAP pacing subtypes was significantly weaker for NDAT-V6 and the RWPT in V6 and V8 (r = 0.681, 0.626, and 0.726, respectively).
conclusionThe NDAT-V8 provides a reliable non-invasive surrogate for the LV posterolateral wall delay during LBBAP, outperforming NDAT-V6 and the RWPT in V6 and V8 and establishes the groundwork for future studies evaluating NDAT-V8 as a tool to guide adequate resynchronization during LBBAP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.